课题基金 / 基金详情

The 4th World Parkinson Congress is a four-day scientific conference designed to bring the US and global Parkinson's community together for a variety of high level and novel educational symposia.

The 4th World Parkinson Congress is a four-day scientific conference designed to bring the US and global Parkinson's community together for a variety of high level and novel educational symposia.
第四届世界帕金森大会是为期四天的科学会议,旨在将美国和全球帕金森病界聚集在一起,举办各种高水平和新颖的教育研讨会。
批准号:
9194917
负责人:
SERGE E PRZEDBORSKI
金额:
$5.0万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-20 至 2017-09-19

项目摘要

项目成果

SERGE E PRZEDBORSKI的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The purpose of the 4th World Parkinson Congress (WPC 2016) is to address a continued need for worldwide dialogue on the multifaceted problems of Parkinsonʼs disease (PD) and to propose solutions, including new approaches to research and better models of care for people with PD. The WPC 2016, to be held from September 20 to 23, 2016, is the only international meeting in the field of Parkinsonʼs that brings the whole PD community together for high- level scientific and lay sessions. Delegates at the meeting represent neuroscientists, physicians, people with PD, care partners, nurses, rehabilitation specialists, social workers, government representatives, and members of the advocacy community from nearly 70 countries. The four-day program highlights advancements in the science of PD and models of care for people living with the disease. Exposing researchers from the US to the scientific advancements made in other parts of the world will help them explore new ideas and build collaborations they might otherwise not have considered. Inclusion and encouragement of junior investigators in this important meeting also allows for networking and exposure to leaders in the field and can inspire those new to PD to stay dedicated to the disease, which is greatly needed! Broad support and involvement from the PD community (over 170 partnering organizations from nearly 50 countries) shows that the WPC is the right venue for these widespread groups to meet and build collaborations. It will allow and encourage interactions between health professionals, researchers, and people with PD and caregivers who might not otherwise meet. Such cross-pollination of experts, as well as advocates, and ideas will spur new innovative research, identify potential solutions to unmet needs, advance therapies for people with PD and inspire delegates to continue their work. Forty-eight committee members, including people with PD (PwP), designed an elaborate program about unique aspects of PD to help deepen the commitment of researchers and clinicians to PD research and foster research on less studied aspects of PD. The program is expected to expose PwPs and caregivers to research and increase interest in participating in clinical trials. Over 180 speakers are being invited from all areas of the PD community with sessions formatted to maximize the learning potential and dialogue, including large and moderately sized as well as incredibly intimate round table sessions with just one expert and 10 participants discussing one assigned topic intensely. The three large morning plenaries will look at the brain circuits in PD and DBS, genes and mechanisms of sporadic PD, and give an update on stem cells and iPs cells. These plenaries will set the stage for further discussion in later sessions each day. There will be both Scientific and Living with Parkinsonʼs posters as well as Poster sessions and tours which are designed to maximize interaction among the delegates. The four most outstanding posters each day in basic and clinical research, clinical therapeutics and quality of life will be presented in an oral ʻHot Topicsʼ session and poster tours will be held, paying keen attention to the most promising work in the field and to increase dialogue and collaboration in the community.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Circuit-specific, chemogenetic neuromodulation in nonhuman primates.
A multiplexable in vivo perturbation toolkit to identify genes affecting neurodegeneration in a model of synucleinopathy
Defining Immune Cell Heterogeneity in Human ALS and Mouse Model of the Disease
Defining immune cell heterogeneity in human ALS and mouse model of the disease
海外基金